<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240611021339&amp;utm_campaign=pubmed-2
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;fc=20230708114047&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20240611021339&amp;utm_campaign=pubmed-2" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 11 Jun 2024 06:13:40 +0000</lastbuilddate>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Correction to: Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease: Using a Genetic Risk Score</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857334/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):e1414. doi: 10.1161/CIR.0000000000001262. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857334/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857334</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001262>10.1161/CIR.0000000000001262</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857334</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease: Using a Genetic Risk Score</dc:title>
<dc:identifier>pmid:38857334</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001262</dc:identifier>
</item>
<item>
<title>Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857333/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):e1413. doi: 10.1161/CIR.0000000000001263. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857333/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857333</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001263>10.1161/CIR.0000000000001263</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857333</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:38857333</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001263</dc:identifier>
</item>
<item>
<title>Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857332/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):e1411. doi: 10.1161/CIR.0000000000001260. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857332/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857332</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001260>10.1161/CIR.0000000000001260</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857332</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2023 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces</dc:title>
<dc:identifier>pmid:38857332</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001260</dc:identifier>
</item>
<item>
<title>Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857331/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):e1412. doi: 10.1161/CIR.0000000000001261. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857331/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857331</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001261>10.1161/CIR.0000000000001261</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857331</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease With and Without Pulmonary Hypertension: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:38857331</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001261</dc:identifier>
</item>
<item>
<title>A Concept of "Athero-Oncology": Tumor-Like Smooth Muscle Cells Drive Atherosclerosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857330/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):1899-1902. doi: 10.1161/CIRCULATIONAHA.124.069446. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857330/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857330</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069446>10.1161/CIRCULATIONAHA.124.069446</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857330</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Payel Chatterjee</dc:creator>
<dc:creator>Kathleen A Martin</dc:creator>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>A Concept of "Athero-Oncology": Tumor-Like Smooth Muscle Cells Drive Atherosclerosis</dc:title>
<dc:identifier>pmid:38857330</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069446</dc:identifier>
</item>
<item>
<title>Novel Mouse Model for Selective Tagging, Purification, and Manipulation of Cardiac Myofibroblasts</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857329/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):1931-1934. doi: 10.1161/CIRCULATIONAHA.123.067754. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857329/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857329</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.123.067754>10.1161/CIRCULATIONAHA.123.067754</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857329</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Vaibhao Janbandhu</dc:creator>
<dc:creator>Vikram Tallapragada</dc:creator>
<dc:creator>Jinyuan Vero Li</dc:creator>
<dc:creator>Bharti Shewale</dc:creator>
<dc:creator>Shila Ghazanfar</dc:creator>
<dc:creator>Ralph Patrick</dc:creator>
<dc:creator>Charles D Cox</dc:creator>
<dc:creator>Richard P Harvey</dc:creator>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Novel Mouse Model for Selective Tagging, Purification, and Manipulation of Cardiac Myofibroblasts</dc:title>
<dc:identifier>pmid:38857329</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.123.067754</dc:identifier>
</item>
<item>
<title>PVC or Not PVC? That Is the Question</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857328/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):1927-1930. doi: 10.1161/CIRCULATIONAHA.124.069404. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857328/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857328</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069404>10.1161/CIRCULATIONAHA.124.069404</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857328</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Pierre Groussin</dc:creator>
<dc:creator>Alex Melot</dc:creator>
<dc:creator>Raphaël P Martins</dc:creator>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>PVC or Not PVC? That Is the Question</dc:title>
<dc:identifier>pmid:38857328</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069404</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857327/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):1921-1926. doi: 10.1161/CIRCULATIONAHA.124.070462. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857327/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857327</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070462>10.1161/CIRCULATIONAHA.124.070462</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857327</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:38857327</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070462</dc:identifier>
</item>
<item>
<title>Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857326/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):1859-1861. doi: 10.1161/CIRCULATIONAHA.124.068244. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857326/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857326</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.068244>10.1161/CIRCULATIONAHA.124.068244</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857326</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>W Gregory Hundley</dc:creator>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Fifty Years of Cardiovascular Magnetic Resonance: Continuing Evolution Toward the "One-Stop Shop" for Cardiovascular Diagnosis</dc:title>
<dc:identifier>pmid:38857326</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.068244</dc:identifier>
</item>
<item>
<title>Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857325/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jun 11;149(24):e1312. doi: 10.1161/CIRCULATIONAHA.124.069221. Epub 2024 Jun 10.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857325/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857325</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069221>10.1161/CIRCULATIONAHA.124.069221</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857325</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Felicita Andreotti</dc:creator>
<dc:creator>Francesco Burzotta</dc:creator>
<dc:creator>Aldo Pietro Maggioni</dc:creator>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Andreotti et al Regarding Article, "Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance"</dc:title>
<dc:identifier>pmid:38857325</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069221</dc:identifier>
</item>
<item>
<title>&lt;em>;Circulation&lt;/em>; Editors and Editorial Board</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38857319/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Jan 2;149(1):1-3. doi: 10.1161/CIR.0000000000001208. Epub 2023 Dec 28.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38857319/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38857319</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001208>10.1161/CIR.0000000000001208</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38857319</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:date>2024-06-10</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>&lt;em>;Circulation&lt;/em>; Editors and Editorial Board</dc:title>
<dc:identifier>pmid:38857319</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001208</dc:identifier>
</item>
<item>
<title>Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38856678/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: In this large cohort of patients with HoFH, evinacumab was generally well tolerated and markedly decreased LDL-C irrespective of age and sex. Moreover, the efficacy and safety of evinacumab was sustained over the long term.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jun 10:ehae325. doi: 10.1093/eurheartj/ehae325. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Homozygous familial hypercholesterolaemia (HoFH) is a rare genetic disorder characterized by severely elevated LDL cholesterol (LDL-C) and premature atherosclerotic cardiovascular disease. In the pivotal Phase 3 HoFH trial (NCT03399786), evinacumab significantly decreased LDL-C in patients with HoFH. This study assesses the long-term safety and efficacy of evinacumab in adult and adolescent patients with HoFH.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: In this open-label, single-arm, Phase 3 trial (NCT03409744), patients aged ≥12 years with HoFH who were evinacumab-naïve or had previously received evinacumab in other trials (evinacumab-continue) received intravenous evinacumab 15 mg/kg every 4 weeks with stable lipid-lowering therapy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 116 patients (adults: n = 102; adolescents: n = 14) were enrolled, of whom 57 (49.1%) were female. Patients were treated for a median (range) duration of 104.3 (28.3-196.3) weeks. Overall, treatment-emergent adverse events (TEAEs) and serious TEAEs were reported in 93 (80.2%) and 27 (23.3%) patients, respectively. Two (1.7%) deaths were reported (neither was considered related to evinacumab). Three (2.6%) patients discontinued due to TEAEs (none were considered related to evinacumab). From baseline to Week 24, evinacumab decreased mean LDL-C by 43.6% [mean (standard deviation, SD), 3.4 (3.2) mmol/L] in the overall population; mean LDL-C reduction in adults and adolescents was 41.7% [mean (SD), 3.2 (3.3) mmol/L] and 55.4% [mean (SD), 4.7 (2.5) mmol/L], respectively.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: In this large cohort of patients with HoFH, evinacumab was generally well tolerated and markedly decreased LDL-C irrespective of age and sex. Moreover, the efficacy and safety of evinacumab was sustained over the long term.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38856678/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38856678</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae325>10.1093/eurheartj/ehae325</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38856678</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Daniel Gaudet</dc:creator>
<dc:creator>Susanne Greber-Platzer</dc:creator>
<dc:creator>Laurens F Reeskamp</dc:creator>
<dc:creator>Gabriella Iannuzzo</dc:creator>
<dc:creator>Robert S Rosenson</dc:creator>
<dc:creator>Samir Saheb</dc:creator>
<dc:creator>Claudia Stefanutti</dc:creator>
<dc:creator>Erik Stroes</dc:creator>
<dc:creator>Albert Wiegman</dc:creator>
<dc:creator>Traci Turner</dc:creator>
<dc:creator>Shazia Ali</dc:creator>
<dc:creator>Poulabi Banerjee</dc:creator>
<dc:creator>Tiera Drewery</dc:creator>
<dc:creator>Jennifer McGinniss</dc:creator>
<dc:creator>Alpana Waldron</dc:creator>
<dc:creator>Richard T George</dc:creator>
<dc:creator>Xue-Qiao Zhao</dc:creator>
<dc:creator>Robert Pordy</dc:creator>
<dc:creator>Jian Zhao</dc:creator>
<dc:creator>Eric Bruckert</dc:creator>
<dc:creator>Frederick J Raal</dc:creator>
<dc:date>2024-06-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy</dc:title>
<dc:identifier>pmid:38856678</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae325</dc:identifier>
</item>
<item>
<title>ANGPTL3 as a therapeutic target for treating homozygous familial hypercholesterolaemia: a shot in the arm for evinacumab</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38856677/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Jun 10:ehae321. doi: 10.1093/eurheartj/ehae321. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38856677/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38856677</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae321>10.1093/eurheartj/ehae321</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38856677</guid>
<pubDate>Mon, 10 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Gerald F Watts</dc:creator>
<dc:creator>Seyed Saeed Tamehri Zadeh</dc:creator>
<dc:creator>Dick C Chan</dc:creator>
<dc:date>2024-06-10</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>ANGPTL3 as a therapeutic target for treating homozygous familial hypercholesterolaemia: a shot in the arm for evinacumab</dc:title>
<dc:identifier>pmid:38856677</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae321</dc:identifier>
</item>
<item>
<title>MTFP1 controls mitochondrial fusion to regulate inner membrane quality control and maintain mtDNA levels</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38851188/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>Mitochondrial dynamics play a critical role in cell fate decisions and in controlling mtDNA levels and distribution. However, the molecular mechanisms linking mitochondrial membrane remodeling and quality control to mtDNA copy number (CN) regulation remain elusive. Here, we demonstrate that the inner mitochondrial membrane (IMM) protein mitochondrial fission process 1 (MTFP1) negatively regulates IMM fusion. Moreover, manipulation of mitochondrial fusion through the regulation of MTFP1 levels...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jun 5:S0092-8674(24)00526-9. doi: 10.1016/j.cell.2024.05.017. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Mitochondrial dynamics play a critical role in cell fate decisions and in controlling mtDNA levels and distribution. However, the molecular mechanisms linking mitochondrial membrane remodeling and quality control to mtDNA copy number (CN) regulation remain elusive. Here, we demonstrate that the inner mitochondrial membrane (IMM) protein mitochondrial fission process 1 (MTFP1) negatively regulates IMM fusion. Moreover, manipulation of mitochondrial fusion through the regulation of MTFP1 levels results in mtDNA CN modulation. Mechanistically, we found that MTFP1 inhibits mitochondrial fusion to isolate and exclude damaged IMM subdomains from the rest of the network. Subsequently, peripheral fission ensures their segregation into small MTFP1-enriched mitochondria (SMEM) that are targeted for degradation in an autophagic-dependent manner. Remarkably, MTFP1-dependent IMM quality control is essential for basal nucleoid recycling and therefore to maintain adequate mtDNA levels within the cell.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38851188/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38851188</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.017>10.1016/j.cell.2024.05.017</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38851188</guid>
<pubDate>Sat, 08 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Luis Carlos Tábara</dc:creator>
<dc:creator>Stephen P Burr</dc:creator>
<dc:creator>Michele Frison</dc:creator>
<dc:creator>Suvagata R Chowdhury</dc:creator>
<dc:creator>Vincent Paupe</dc:creator>
<dc:creator>Yu Nie</dc:creator>
<dc:creator>Mark Johnson</dc:creator>
<dc:creator>Jara Villar-Azpillaga</dc:creator>
<dc:creator>Filipa Viegas</dc:creator>
<dc:creator>Mayuko Segawa</dc:creator>
<dc:creator>Hanish Anand</dc:creator>
<dc:creator>Kasparas Petkevicius</dc:creator>
<dc:creator>Patrick F Chinnery</dc:creator>
<dc:creator>Julien Prudent</dc:creator>
<dc:date>2024-06-08</dc:date>
<dc:source>Cell</dc:source>
<dc:title>MTFP1 controls mitochondrial fusion to regulate inner membrane quality control and maintain mtDNA levels</dc:title>
<dc:identifier>pmid:38851188</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.017</dc:identifier>
</item>
<item>
<title>The rate and nature of mitochondrial DNA mutations in human pedigrees</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38851187/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>We examined the rate and nature of mitochondrial DNA (mtDNA) mutations in humans using sequence data from 64,806 contemporary Icelanders from 2,548 matrilines. Based on 116,663 mother-child transmissions, 8,199 mutations were detected, providing robust rate estimates by nucleotide type, functional impact, position, and different alleles at the same position. We thoroughly document the true extent of hypermutability in mtDNA, mainly affecting the control region but also some coding-region...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jun 3:S0092-8674(24)00531-2. doi: 10.1016/j.cell.2024.05.022. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">We examined the rate and nature of mitochondrial DNA (mtDNA) mutations in humans using sequence data from 64,806 contemporary Icelanders from 2,548 matrilines. Based on 116,663 mother-child transmissions, 8,199 mutations were detected, providing robust rate estimates by nucleotide type, functional impact, position, and different alleles at the same position. We thoroughly document the true extent of hypermutability in mtDNA, mainly affecting the control region but also some coding-region variants. The results reveal the impact of negative selection on viable deleterious mutations, including rapidly mutating disease-associated 3243A>;G and 1555A>;G and pre-natal selection that most likely occurs during the development of oocytes. Finally, we show that the fate of new mutations is determined by a drastic germline bottleneck, amounting to an average of 3 mtDNA units effectively transmitted from mother to child.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38851187/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38851187</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.022>10.1016/j.cell.2024.05.022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38851187</guid>
<pubDate>Sat, 08 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Erla R Árnadóttir</dc:creator>
<dc:creator>Kristján H S Moore</dc:creator>
<dc:creator>Valdís B Guðmundsdóttir</dc:creator>
<dc:creator>S Sunna Ebenesersdóttir</dc:creator>
<dc:creator>Kamran Guity</dc:creator>
<dc:creator>Hákon Jónsson</dc:creator>
<dc:creator>Kári Stefánsson</dc:creator>
<dc:creator>Agnar Helgason</dc:creator>
<dc:date>2024-06-08</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The rate and nature of mitochondrial DNA mutations in human pedigrees</dc:title>
<dc:identifier>pmid:38851187</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.022</dc:identifier>
</item>
<item>
<title>RNA interference lowers triglyceride levels</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38849676/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2024 Jun 7. doi: 10.1038/s41569-024-01052-8. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38849676/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38849676</a> | DOI:<a href=https://doi.org/10.1038/s41569-024-01052-8>10.1038/s41569-024-01052-8</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38849676</guid>
<pubDate>Fri, 07 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Gregory B Lim</dc:creator>
<dc:date>2024-06-07</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>RNA interference lowers triglyceride levels</dc:title>
<dc:identifier>pmid:38849676</dc:identifier>
<dc:identifier>doi:10.1038/s41569-024-01052-8</dc:identifier>
</item>
<item>
<title>Isthmus progenitor cells contribute to homeostatic cellular turnover and support regeneration following intestinal injury</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38848678/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>The currently accepted intestinal epithelial cell organization model proposes that Lgr5^(+) crypt-base columnar (CBC) cells represent the sole intestinal stem cell (ISC) compartment. However, previous studies have indicated that Lgr5^(+) cells are dispensable for intestinal regeneration, leading to two major hypotheses: one favoring the presence of a quiescent reserve ISC and the other calling for differentiated cell plasticity. To investigate these possibilities, we studied crypt epithelial...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jun 6;187(12):3056-3071.e17. doi: 10.1016/j.cell.2024.05.004.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The currently accepted intestinal epithelial cell organization model proposes that Lgr5<sup>+</sup> crypt-base columnar (CBC) cells represent the sole intestinal stem cell (ISC) compartment. However, previous studies have indicated that Lgr5<sup>+</sup> cells are dispensable for intestinal regeneration, leading to two major hypotheses: one favoring the presence of a quiescent reserve ISC and the other calling for differentiated cell plasticity. To investigate these possibilities, we studied crypt epithelial cells in an unbiased fashion via high-resolution single-cell profiling. These studies, combined with in vivo lineage tracing, show that Lgr5 is not a specific ISC marker and that stemness potential exists beyond the crypt base and resides in the isthmus region, where undifferentiated cells participate in intestinal homeostasis and regeneration following irradiation (IR) injury. Our results provide an alternative model of intestinal epithelial cell organization, suggesting that stemness potential is not restricted to CBC cells, and neither de-differentiation nor reserve ISC are drivers of intestinal regeneration.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38848678/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38848678</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11164536/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">PMC11164536</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.004>10.1016/j.cell.2024.05.004</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38848678</guid>
<pubDate>Fri, 07 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Ermanno Malagola</dc:creator>
<dc:creator>Alessandro Vasciaveo</dc:creator>
<dc:creator>Yosuke Ochiai</dc:creator>
<dc:creator>Woosook Kim</dc:creator>
<dc:creator>Biyun Zheng</dc:creator>
<dc:creator>Luca Zanella</dc:creator>
<dc:creator>Alexander L E Wang</dc:creator>
<dc:creator>Moritz Middelhoff</dc:creator>
<dc:creator>Henrik Nienhüser</dc:creator>
<dc:creator>Lu Deng</dc:creator>
<dc:creator>Feijing Wu</dc:creator>
<dc:creator>Quin T Waterbury</dc:creator>
<dc:creator>Bryana Belin</dc:creator>
<dc:creator>Jonathan LaBella</dc:creator>
<dc:creator>Leah B Zamechek</dc:creator>
<dc:creator>Melissa H Wong</dc:creator>
<dc:creator>Linheng Li</dc:creator>
<dc:creator>Chandan Guha</dc:creator>
<dc:creator>Chia-Wei Cheng</dc:creator>
<dc:creator>Kelley S Yan</dc:creator>
<dc:creator>Andrea Califano</dc:creator>
<dc:creator>Timothy C Wang</dc:creator>
<dc:date>2024-06-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Isthmus progenitor cells contribute to homeostatic cellular turnover and support regeneration following intestinal injury</dc:title>
<dc:identifier>pmid:38848678</dc:identifier>
<dc:identifier>pmc:PMC11164536</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.004</dc:identifier>
</item>
<item>
<title>Time-resolved fate mapping identifies the intestinal upper crypt zone as an origin of Lgr5+ crypt base columnar cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38848677/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>In the prevailing model, Lgr5+ cells are the only intestinal stem cells (ISCs) that sustain homeostatic epithelial regeneration by upward migration of progeny through elusive upper crypt transit-amplifying (TA) intermediates. Here, we identify a proliferative upper crypt population marked by Fgfbp1, in the location of putative TA cells, that is transcriptionally distinct from Lgr5+ cells. Using a kinetic reporter for time-resolved fate mapping and Fgfbp1-CreER^(T2) lineage tracing, we establish...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jun 6;187(12):3039-3055.e14. doi: 10.1016/j.cell.2024.05.001.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">In the prevailing model, Lgr5+ cells are the only intestinal stem cells (ISCs) that sustain homeostatic epithelial regeneration by upward migration of progeny through elusive upper crypt transit-amplifying (TA) intermediates. Here, we identify a proliferative upper crypt population marked by Fgfbp1, in the location of putative TA cells, that is transcriptionally distinct from Lgr5+ cells. Using a kinetic reporter for time-resolved fate mapping and Fgfbp1-CreER<sup>T2</sup> lineage tracing, we establish that Fgfbp1+ cells are multi-potent and give rise to Lgr5+ cells, consistent with their ISC function. Fgfbp1+ cells also sustain epithelial regeneration following Lgr5+ cell depletion. We demonstrate that FGFBP1, produced by the upper crypt cells, is an essential factor for crypt proliferation and epithelial homeostasis. Our findings support a model in which tissue regeneration originates from upper crypt Fgfbp1+ cells that generate progeny propagating bi-directionally along the crypt-villus axis and serve as a source of Lgr5+ cells in the crypt base.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38848677/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38848677</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.001>10.1016/j.cell.2024.05.001</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38848677</guid>
<pubDate>Fri, 07 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Claudia Capdevila</dc:creator>
<dc:creator>Jonathan Miller</dc:creator>
<dc:creator>Liang Cheng</dc:creator>
<dc:creator>Adam Kornberg</dc:creator>
<dc:creator>Joel J George</dc:creator>
<dc:creator>Hyeonjeong Lee</dc:creator>
<dc:creator>Theo Botella</dc:creator>
<dc:creator>Christine S Moon</dc:creator>
<dc:creator>John W Murray</dc:creator>
<dc:creator>Stephanie Lam</dc:creator>
<dc:creator>Ruben I Calderon</dc:creator>
<dc:creator>Ermanno Malagola</dc:creator>
<dc:creator>Gary Whelan</dc:creator>
<dc:creator>Chyuan-Sheng Lin</dc:creator>
<dc:creator>Arnold Han</dc:creator>
<dc:creator>Timothy C Wang</dc:creator>
<dc:creator>Peter A Sims</dc:creator>
<dc:creator>Kelley S Yan</dc:creator>
<dc:date>2024-06-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Time-resolved fate mapping identifies the intestinal upper crypt zone as an origin of Lgr5+ crypt base columnar cells</dc:title>
<dc:identifier>pmid:38848677</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.001</dc:identifier>
</item>
<item>
<title>A developmental constraint model of cancer cell states and tumor heterogeneity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38848676/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>Cancer is a disease that stems from a fundamental liability inherent to multicellular life forms in which an individual cell is capable of reneging on the interests of the collective organism. Although cancer is commonly described as an evolutionary process, a less appreciated aspect of tumorigenesis may be the constraints imposed by the organism's developmental programs. Recent work from single-cell transcriptomic analyses across a range of cancer types has revealed the recurrence, plasticity,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jun 6;187(12):2907-2918. doi: 10.1016/j.cell.2024.04.032.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cancer is a disease that stems from a fundamental liability inherent to multicellular life forms in which an individual cell is capable of reneging on the interests of the collective organism. Although cancer is commonly described as an evolutionary process, a less appreciated aspect of tumorigenesis may be the constraints imposed by the organism's developmental programs. Recent work from single-cell transcriptomic analyses across a range of cancer types has revealed the recurrence, plasticity, and co-option of distinct cellular states among cancer cell populations. Here, we note that across diverse cancer types, the observed cell states are proximate within the developmental hierarchy of the cell of origin. We thus posit a model by which cancer cell states are directly constrained by the organism's "developmental map." According to this model, a population of cancer cells traverses the developmental map, thereby generating a heterogeneous set of states whose interactions underpin emergent tumor behavior.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38848676/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38848676</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.032>10.1016/j.cell.2024.04.032</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38848676</guid>
<pubDate>Fri, 07 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Ayushi S Patel</dc:creator>
<dc:creator>Itai Yanai</dc:creator>
<dc:date>2024-06-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A developmental constraint model of cancer cell states and tumor heterogeneity</dc:title>
<dc:identifier>pmid:38848676</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.032</dc:identifier>
</item>
<item>
<title>A simple rule for predicting function of microbial communities</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38848675/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>Microbial communities perform many important functions, such as carbon sequestration, decomposition, pathogen resistance, etc., but quantitatively predicting functions of new communities remains a major challenge. In this issue of Cell, Diaz-Colunga et al. report a new simple statistical regularity that enables such predictions.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jun 6;187(12):2905-2906. doi: 10.1016/j.cell.2024.04.024.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Microbial communities perform many important functions, such as carbon sequestration, decomposition, pathogen resistance, etc., but quantitatively predicting functions of new communities remains a major challenge. In this issue of Cell, Diaz-Colunga et al. report a new simple statistical regularity that enables such predictions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38848675/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38848675</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.04.024>10.1016/j.cell.2024.04.024</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38848675</guid>
<pubDate>Fri, 07 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Sergey Kryazhimskiy</dc:creator>
<dc:date>2024-06-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A simple rule for predicting function of microbial communities</dc:title>
<dc:identifier>pmid:38848675</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.04.024</dc:identifier>
</item>
<item>
<title>Unveiling of a messenger: Gut microbes make a neuroactive signal</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/38848674/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20240611021339&amp;v=2.18.0.post9+e462414
      <description>Gut microbes are known to impact host physiology in several ways. However, key molecular players in host-commensal interactions remain to be uncovered. In this issue of Cell, McCurry et al. reveal that gut bacteria perform 21-dehydroxylation to convert abundant biliary corticoids to neurosteroids using readily available H(2) in their environment.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2024 Jun 6;187(12):2903-2904. doi: 10.1016/j.cell.2024.05.014.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Gut microbes are known to impact host physiology in several ways. However, key molecular players in host-commensal interactions remain to be uncovered. In this issue of Cell, McCurry et al. reveal that gut bacteria perform 21-dehydroxylation to convert abundant biliary corticoids to neurosteroids using readily available H<sub>2</sub> in their environment.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/38848674/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20240611021339&v=2.18.0.post9+e462414">38848674</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2024.05.014>10.1016/j.cell.2024.05.014</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:38848674</guid>
<pubDate>Fri, 07 Jun 2024 06:00:00 -0400</pubDate>
<dc:creator>Poulami Chatterjee</dc:creator>
<dc:creator>Laura M K Dassama</dc:creator>
<dc:date>2024-06-07</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Unveiling of a messenger: Gut microbes make a neuroactive signal</dc:title>
<dc:identifier>pmid:38848674</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2024.05.014</dc:identifier>
</item>





























</channel>
</rss>